Mutant gene-targeted immunotherapy approach developed
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer
Read more
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer
Read moreInoculation with an Ebola virus that has mutations in a protein called VP35 does not cause disease and elicits protection
Read more